(Q54464415)

30 May 2018

title

Effect of metformin on survival rate in experimental sepsis. (English)

1 reference

30 May 2018

1 reference

1 reference

Gras V

1

1 reference

30 May 2018

Bouffandeau B

series ordinal

2

1 reference

30 May 2018

Montravers PH

series ordinal

3

1 reference

30 May 2018

Lalau JD

series ordinal

4

1 reference

30 May 2018

publication date

1 April 2006

1 reference

30 May 2018

published in

Diabetes and Metabolism

1 reference

30 May 2018

volume

32

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

147-150

1 reference

30 May 2018

Re-evaluation of a biguanide, metformin: mechanism of action and tolerability

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Lactic acidosis in patients with diabetes treated with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Role of metformin accumulation in metformin-associated lactic acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Metformin and lactic acidosis in diabetic humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Disposition of metformin (N,N-dimethylbiguanide) in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Clinical pharmacokinetics of metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Accumulation of metformin by tissues of the normal and diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Severe bloodstream infections: a population-based assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Metformin: intrinsic vasculoprotective properties

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970261-6

7 January 2021

10.1016/S1262-3636(07)70261-6

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018